Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.
<h4>Background</h4>The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme patients. However, TMZ resistance may be one of the main reasons why treatment fails. Although this resistance has frequently been linked to the expression of O6-methylguanine-DNA meth...
Saved in:
| Main Authors: | Gloria Perazzoli, Jose Prados, Raul Ortiz, Octavio Caba, Laura Cabeza, Maria Berdasco, Beatriz Gónzalez, Consolación Melguizo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0140131&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma
by: Jiabing Li, et al.
Published: (2025-08-01) -
Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma
by: Diego Carrillo-Beltrán, et al.
Published: (2025-01-01) -
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
by: Dipongkor Saha, et al.
Published: (2020-05-01) -
CHANGES IN THE MGMT GENE EXPRESSION IN PATIENTS WITH PRIMARY GLIOBLASTOMA AFTER RELAPSE. INFLUENCE OF CLINICAL CHARACTERISTICS AND MGMT EXPRESSION ON SURVIVAL OF PATIENTS
by: M. V. Matsko, et al.
Published: (2021-06-01) -
Varieties of interactions of anti-CD133 aptamers with cell cultures from patient glioblastoma
by: Olga Antipova, et al.
Published: (2024-12-01)